期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

p16基因在K562/A02细胞株表达情况的研究 被引量：1

Research of expression of p16 gene in K562/A02 cell line
下载PDF
导出
摘要 目的:研究p16基因在K562/A02细胞株的表达情况及其与耐药的关系。方法:用PCR法对慢性髓系白血病细胞株K562及其耐药细胞株K562/A02进行p16基因缺失检测。结果:K562及K562/A02细胞株经PCR扩增后,均未扩出相应条带。结论:K562/A02细胞株与K562细胞株一样,均表现为p16基因缺失。 Objective To discuss the expression of p16 gene in K562/A02 cell line and the relationship between the expression of p16 gene and muhidrug resistance. Method Polymerase chain reaction method was used to detect the expression of p16 gene. Result After PCR, both K562 and K562/A02 cell line had not been found to have amplified stripes. Conclusion Both K562 and K562/A02 cell line show deletion of p16 gene.
作者 寿倍明 陈宝安 周冬蕊 刘德龙 丁家华 高冲 孙耘玉 王骏 程坚 赵刚 宋慧慧 鲍文 陆祖宏
机构地区 东南大学临床医学院 东南大学附属中大医院血液科 东南大学生物科学与医学工程学院 纽约医学院医学部
出处 《东南大学学报（医学版）》 CAS 2008年第3期151-153,共3页 Journal of Southeast University(Medical Science Edition)
基金 国家自然科学基金资助项目(39970832)
关键词 P16基因 K562细胞株 K562/A02细胞株 表达 缺失 p16 gene K562 cell line K562/A02 cell line expression deletion
分类号 Q786 [生物学—分子生物学] R733.72 [医药卫生—肿瘤]
  • 相关文献

参考文献11

  • 1KAMB A,GRUIS N A,WEAVER-FELDHAUS J,et al. A cell cycle regulator potentially involved in genesis of many tumor types[ J]. Science, 1994,264( 5157 ) :436-440.
  • 2QUESNEL B, PREUDHOMME C, HETUIN D,et al. Transfer of P16inka/CDKN2 gene in leukemic cell lines inhibits cell proliferation [ J ]. Br J itaematol, 1996,9.5 ( 2 ) :291-298.
  • 3BOULTWOOD J, WAINSCOAT J S. Gene silencing by DNA methylation in haematological malignancies[ J]. Br J Haematol, 2007,138( 1 ) :3-11.
  • 4芮红兵,苏津自,卓光生,康日辉,林珺芳.抑癌基因c与p53抑制白血病细胞株生长作用的比较[J].白血病．淋巴瘤,2007,16(1):15-18. 被引量：5
  • 5KUSABA H,NAKAYA M,HARADA T,et al. Maintenance of hypomethylation status and preferential expression of exogenous human MDRI/PGY1 gene in mouse L cells by YAC mediated /ransfer[ J ]. Somat Cell Mol Genett, 1997,23 (4) :259-263.
  • 6WORM J, KIRKIN A F, DZHANDZHUGAZYAN K N, et al.Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells [ J ]. J Biol Chem, 2001,276 ( 43 ) :39990-40000.
  • 7NAKAYAMA M, WADA M, HARADA T,et al. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias[ J ]. Blood, 1998,92 ( 11 ) :4296-4307.
  • 8朱燕,武淑兰,卜定方,李渊,朱强,曹香红.恶性血液病患者mdr1基因启动子区甲基化状态及其与表达的关系[J].中国实验血液学杂志,2004,12(1):6-10. 被引量：6
  • 9LU L,KATSAROS D,WILEY A,et al. Expression of MDR1 in epithelial ovarian cancer and its association with disease progression [J]. Oncol Res,2007,16(8) :395-403.
  • 10RUSCH V, KLIMSTRA D, VEMKATRAMAN E, et al. Aberrant p53 expression predicts clinical resistance to cisplation- based chemotherapy in locally advanced non-small cell lung cancer[ J ]. Cancer Res, 1995,55 (21) :5038-5042.

二级参考文献27

  • 1庄静丽,徐建民,王宝珍,吴直江,高奇蓉.急性白血病p53蛋白表达的临床意义[J].中国临床医学,2005,12(3):504-505. 被引量：1
  • 2[1]Ogretmen B, Safa AR. Identification and characterization of the MDR1 promoter-enhancing factor 1 (MEF1) in the multidrug resistant HL60/VCR human acute myeloid leukemia cell line. Biochemistry, 2000; 39:194-204
  • 3[2]Jurcic JG, Larson SM, Sgouros G, et al. Targeted alpha particle immunotherapy for myeloid leukemia. Blood, 2002; 100: 1233-1239
  • 4[3]Kusaba H, Nakayarna M, Harada T, et al. Maintenance of hypomethylation status and preferential expression of exogenous human MDR1/PGY1 gene in mouse L cells by YAC mediated transfer. Somat Cell Mol Genet, 1997; 23:259- 274
  • 5[4]Nakayama M, Wada M, Harada T, et al. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. Blood, 1998; 92: 42964307
  • 6[5]Tada Y, Wada M, Kuroiwa K, et al. MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment. Clin Cancer res, 2000;6:4618-4627
  • 7[6]Toyota M, Kopecky KJ, Toyota MO, et al. Methylation profiling in acute myeloid leukemia. Blood, 2001; 97:2823- 2829
  • 8[7]Garcia-Manero G, Bueso-Ramos C, Daniel J, et al. DNA methylation patterns at relapse in adult acute lymphocytic leukemia. Clin Cancer Res,2002; 8:1897 - 1903
  • 9[8]Fryxell KB, McGee SB, Simoneaux DK, et al. Methylation analysis of the human multidrug resistance 1 gene in normal and leukemic hematopoietic cells. Leukemia, 1999; 13:910-917
  • 10[9]Ando T, Nishimura M, Oka Y. Decitabine (5-Aza-2-deoxycyti dine) decreased DNA methylation and expression of MDRl gene in K562/ADM cells. Leukemia, 2000; 14:1915-1920

共引文献21

同被引文献2

引证文献1

二级引证文献7

东南大学学报（医学版）
2008年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部